Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Myeloid Leukemias After Undergoing Allogeneic Stem Cell Transplantation

This study has been suspended.

Study NCT00052598 Information provided by National Cancer Institute (NCI)

First Received: January 24, 2003 Last Updated: July 11, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)